glp-1 triple agonist retatrutide gip glucagon phase 2 obesity trial Dual and Gut Peptide Agonists Retatrutide Triple Agonist Peptide |

Heightened systemic inflammatory states appear to worsen COVID-19 outcomes by initiating a counter-regulatory response, which includes the upregulation of levels of the ACE2 receptor and its associated peptidases 11

Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mulsch A, Schulz E, Keaney Jr JF, Stamler JS, Munzel T

It also suppresses TGF-alpha/Smad 2/3 signaling to reduce fibrotic tissue formation and promote balanced remodeling 3

S2CID 24183761

The fibrogenesis shows varying degrees, from mild to intense, until the formation of dense bundles that give the appearance of a desmoplastic or sometimes neuroid lesion